abrdn plc trimmed its stake in shares of Eastman Chemical (NYSE:EMN - Free Report) by 14.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,709 shares of the basic materials company's stock after selling 4,532 shares during the period. abrdn plc's holdings in Eastman Chemical were worth $2,526,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also bought and sold shares of the company. Crews Bank & Trust purchased a new position in Eastman Chemical in the fourth quarter valued at $27,000. Wolff Wiese Magana LLC increased its stake in shares of Eastman Chemical by 238.1% in the 3rd quarter. Wolff Wiese Magana LLC now owns 284 shares of the basic materials company's stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. Dunhill Financial LLC raised its stake in shares of Eastman Chemical by 94.7% during the 3rd quarter. Dunhill Financial LLC now owns 333 shares of the basic materials company's stock worth $37,000 after buying an additional 162 shares during the period. Northwest Investment Counselors LLC purchased a new stake in Eastman Chemical in the 3rd quarter worth $38,000. Finally, Exchange Traded Concepts LLC raised its position in Eastman Chemical by 784.4% during the third quarter. Exchange Traded Concepts LLC now owns 681 shares of the basic materials company's stock worth $76,000 after acquiring an additional 604 shares during the period. Hedge funds and other institutional investors own 83.65% of the company's stock.
Insider Activity at Eastman Chemical
In related news, EVP Stephen Glenn Crawford sold 10,504 shares of Eastman Chemical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $105.00, for a total value of $1,102,920.00. Following the transaction, the executive vice president now directly owns 47,287 shares in the company, valued at $4,965,135. This trade represents a 18.18 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Julie A. Mcalindon sold 4,456 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $105.84, for a total transaction of $471,623.04. Following the transaction, the senior vice president now directly owns 4,403 shares of the company's stock, valued at $466,013.52. This represents a 50.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.93% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on EMN. StockNews.com raised shares of Eastman Chemical from a "hold" rating to a "buy" rating in a research note on Saturday, January 18th. Bank of America upgraded Eastman Chemical from a "neutral" rating to a "buy" rating and cut their price objective for the stock from $115.00 to $109.00 in a research note on Tuesday, January 14th. Piper Sandler upped their target price on shares of Eastman Chemical from $102.00 to $105.00 and gave the stock a "neutral" rating in a report on Thursday. JPMorgan Chase & Co. raised their price target on shares of Eastman Chemical from $110.00 to $112.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Finally, Royal Bank of Canada upped their price objective on shares of Eastman Chemical from $101.00 to $103.00 and gave the company a "sector perform" rating in a research note on Tuesday, February 4th. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to MarketBeat, Eastman Chemical has an average rating of "Moderate Buy" and an average price target of $113.77.
Check Out Our Latest Stock Analysis on EMN
Eastman Chemical Trading Up 0.4 %
Shares of NYSE EMN traded up $0.36 during mid-day trading on Thursday, reaching $101.64. 744,360 shares of the company's stock were exchanged, compared to its average volume of 1,157,674. The company's 50-day moving average is $94.26 and its 200-day moving average is $100.18. Eastman Chemical has a 52-week low of $81.76 and a 52-week high of $114.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.78 and a current ratio of 1.52. The firm has a market capitalization of $11.78 billion, a price-to-earnings ratio of 13.23, a PEG ratio of 1.24 and a beta of 1.44.
Eastman Chemical (NYSE:EMN - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The basic materials company reported $1.87 earnings per share for the quarter, topping analysts' consensus estimates of $1.60 by $0.27. Eastman Chemical had a net margin of 9.65% and a return on equity of 16.40%. Analysts expect that Eastman Chemical will post 8.47 EPS for the current fiscal year.
Eastman Chemical Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, April 7th. Investors of record on Friday, March 14th will be paid a dividend of $0.83 per share. This represents a $3.32 annualized dividend and a yield of 3.27%. Eastman Chemical's payout ratio is 43.23%.
Eastman Chemical Profile
(
Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
Further Reading

Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.